Jardines and the economics of dissent

When a coalition of investors turned their legal fire on Jardine Strategic in 2021 to seek “fair value” for their shares in a controversial squeeze-out, Bermuda had no domestic precedents, and litigants were left to guess how receptive the courts would be.

But in Cayman—where shareholder protections are thin and forced buyouts easy to execute—minority investors, soon branded “dissenters”, were increasingly willing to take companies on. A run of decisions, some reaching the Privy Council in London, was shaping the modern playbook for offshore fair-value disputes. 

A major catalyst was the steady stream of PRC companies delisting from US markets. Investors quickly learned that Cayman and Bermuda deal structures allowed controlling shareholders wide scope to force through buyouts at strikingly low premiums. Hedge funds discovered a lucrative opportunity.

A niche statutory remedy soon spawned a thriving cottage industry as event-driven funds piled into “appraisal arbitrage”, buying up shares after a squeeze-out was announced on a wager that judges would set a higher fair value. Early wins revealed a simple truth: the deal price often bore little resemblance to the underlying economic value of the business.

For several years dissenters enjoyed a receptive climate and regular uplifts on prices as the Cayman court became an arena for duelling valuations, each side arguing its figure was the truer measure of a company’s worth.

But the judicial mood appears to be cooling. Recent cases suggest judges are growing wary of dissenter valuations that stray too far from commercial reality and companies are sharpening deal processes that make uplifts harder to win.

Delaware has already been down this road. Once a high-return strategy for hedge funds, appraisal arbitrage eventually thinned out as judicial scrutiny intensified. With the Jardines case still likely to run for years, the economics of dissent could look rather different by the time it reaches trial.

The golden era of uplift

Given limited minority protections in Cayman and Bermuda law, controlling shareholders face few obstacles to executing take-privates at prices well below underlying value. Unlike Delaware, there is no general fairness test. There is no need for an independent committee, a minority veto or scrutiny by financial advisors. If minorities think the offer price is too low, the burden falls on them to dissent afterwards and fight for fair value in court.

A regime for fair value redress only made it to Cayman’s statute books in in 2009 (in Bermuda it was 2001), and the first reported case was not until 2015 when investors holding 17% of Integra Group, a Russian oil-field services company listed in London, challenged a US$10 deal price in a US$89.7 million management buy-out. They received a comfortable 17% uplift on the deal price from the court, taking home a judgment sum of just under US$20 million.

The next major case was Shanda Games, a Nasdaq-listed Chinese gaming company which offered US$3.55 per share in a US$1.9 billion take-private. Holders of just 1.64% dissented and in 2017 secured US$8.34 per share—an uplift of 135%, later reduced on appeal to US$6.42 per share (around 80%). The ultimate payout was roughly US$57 million.

The courts continued to deliver uplifts, some more modest than others. In 2019, dissenters in Qunar, a Chinese online travel platform, achieved an uplift of around 2%. That same year, dissenters in Nord Anglia, an education group, secured a far more substantial 16% increase over the company’s valuation. By 2020, the trend toward slimmer gains continued: in Trina Solar, dissenters beat the company’s number by just 1.29%.

As more cases arrived, the courts deepened their toolkit. Judges applied both market-based methods such as trading or merger price as well as discounted cash-flow analysis, sometimes blending them, sometimes using one as a cross-check against the other.

They demanded extensive discovery, compelled production of internal forecasts, probed the independence of financial advisors, questioned transaction committees, and even met valuation experts directly. In effect, they built a procedural fairness framework despite having no statutory fairness test.

These actions created an offshore cottage industry of litigation funders, legal advisors, valuation specialists and expert witnesses. Geopolitics provided a steady pipeline of opportunities as PRC companies continued to exit US markets.

As the jurisprudence matured—reinforced by Privy Council rulings—dissenters gained confidence and continued to secure uplifts. DCF valuations grounded in future cash-flow forecasts proved an effective counter to low merger prices controlling shareholders could set, and for a time, it proved the most convincing story in the courtroom. Many disputes settle confidentially, suggesting the true success rate was almost certainly higher than publicly recorded.

Some remarkable gains in recent cases include the 2024 Xingxuan Technology challenge, where dissenting shareholders received a 659% uplift on the merger consideration from a Cayman court (partly explained by the fact the trial was uncontested by the company). In Bermuda’s first fair value trial, involving ASX-listed NKWE Platinum, the Supreme Court in February 2025 awarded dissenting shareholders a 23% increase on the A$0.13 offer price.

A high-profile target takes centre stage

Jardine Strategic stepped into the arena just as the offshore dissenter movement was finding its stride. Investors beyond the usual hedge-fund cohort joined the challenge, convinced the offer price fell well short of fair value. The company itself—a highly liquid, family-run, household name conglomerate—made it a conspicuous target.

Jardine Matheson in 2021 had bought the 15% of Jardine Strategic it did not already own, at US$33 per share. The deal passed easily—Bermuda law imposed no related-party protections—but opposition from independent shareholders was overwhelming: 76.9% of them voted against the transaction, according to figures from BlackRock (the investment firm used the Jardine Strategic case to illustrate loopholes that secondary listings exploit in a 2021 regulatory submission).

Around the same time, Jardine Strategic in an interim results announcement revealed a net asset value of US$58.22 per share, a 76% premium to the offer price. Around 90 plaintiff shareholders invoked Bermuda’s fair value regime, most of whom had bought their shares after the deal was announced, fully aware it would close. Jardines itself estimated that 84% of plaintiffs were pursuing appraisal arbitrage.

The dispute became emblematic of offshore dissent. Trading volume in Jardine Strategic surged from US$10 million a day to US$150 million after the announcement, fuelled by hedge funds “drumming up business” for a dissenter pile-in, according to remarks made in court by counsel.

The case—now four years in—will subject Jardine Strategic’s valuation, deal process, transaction committee and advisors to a level of forensic scrutiny likely not yet seen in offshore appraisal actions. It is shaping up to be one of the most fact-intensive and high-stakes dissenter cases yet.

A more nuanced landscape?

But a string of recent cases suggests a subtle shift in the Cayman courts’ mood. Judges are increasingly wary of intrinsic valuations that sit worlds away from commercial reality and appear reluctant to let dissenters walk off with outsized gains.

The decisions point to a quiet shift toward a more Delaware-style approach that accords greater weight to real-world market evidence—generally favoured by corporates—over the cash-flow valuations built on optimistic forecasts that dissenters have long relied upon.

The 2022 appraisal of NYSE-listed life insurer FGL Holdings marked a watershed: for the first time, a Cayman court affirmed the merger price as fair value. It showed that in the right circumstances (a transaction conducted in a competitive, arms-length manner, with reliable market signals and a credible company valuation) dissenters could not bank on an uplift.

That message was amplified in November 2025, when the court in the appraisal of Chinese human-resources platform 51job Inc rejected the dissenters’ valuation outright—more than triple the merger price—describing it as “from another planet in another galaxy… totally removed from the real world the company occupied… it only exists in the dissenters’ speculative, distorted and unreliable DCF spreadsheet.” Again, the merger price carried the day.

Judges enjoy broad discretion in deciding which side’s valuation is more persuasive, and corporates have become better at addressing weaknesses—thin disclosure, patchy record-keeping, questionable independence—that once left their take-privates exposed. They are also tightening pricing to reflect the risk of dissent, leaving less room for any later judicial uplift.

The emerging message from the courts is: do not drift too far from economic reality. That carries clear implications for Jardine Strategic as dissenters calibrate what they believe fair value should be [see our article “Did Jardines shortchange investors by US$4 billion?”]—and for shareholders facing a new wave of PRC issuers retreating from US capital markets.

The dreaded Delaware paradox

Several large, complex appraisal cases—58.com, Sina and others—are currently awaiting judgment in Cayman, with more gearing up for trial. How they are resolved could shed light on whether the recent judicial tone marks a temporary wobble or a more durable shift.

That question matters because history suggests appraisal arbitrage has natural limits. The strategy only works when the spread between the merger price and intrinsic value is wide enough to justify years of litigation. If judges baulk at overly optimistic DCF valuations and companies learn to price deals and conduct themselves in ways that are harder for dissenters to challenge, that spread narrows. When that happens, the economic appeal inevitably diminishes, even for the most aggressive funds.

Delaware has already lived through such a boom and bust. A decade ago, hedge funds flocked to its courts for appraisals when uplifts were generous. Companies responded with cleaner processes and higher offer prices, often building a “dissenter premium” into deals. The state’s Supreme Court then delivered a string of decisions, Dell, DFC, and Aruba, giving greater weight to market evidence and narrowing the scope for valuation uplifts. As spreads compressed and awards fell, the strategy lost its economic appeal.

Offshore courts may not yet be at that inflection point, but the parallels are becoming harder to ignore. And as Cayman and Bermuda sharpen their approach and build a clearer body of precedent, outcomes may become more predictable—and potentially less lucrative.

Yet this is not necessarily to the detriment of minority shareholders. Offshore judges have become far more exacting in interrogating how a company constructs an offer price in a squeeze-out. The bar has risen sharply for any company seeking to persuade a court that the number it puts on the table represents a defensible view of fair value. Companies may yet decide that they cannot force out minorities at meagre premiums.

Copyright: Ninepin Ltd, 2026